UTMB restricting antibody treatment to people most at risk
The Galveston County Daily News, December 29, 2021
Faced with increased demand and dwindling supplies, the University of Texas Medical Branch is rationing an antibody treatment shown to be effective against COVID-19, restricting the medicine to the sickest and most at-risk people, including some who are unvaccinated. People eligible for the antibody treatment include those not expected to mount an adequate immune response and some unvaccinated people, including anyone 65 years of age or older, said Dr. Gulshan Sharma, the medical branch’s chief medical officer.